India Glycols Ltd
₹ 383
19.99%
07 Oct
- close price
- Market Cap ₹ 2,567 Cr.
- Current Price ₹ 383
- High / Low ₹ 383 / 168
- Stock P/E 8.10
- Book Value ₹ 438
- Dividend Yield 1.96 %
- ROCE 12.4 %
- ROE 11.3 %
- Face Value ₹ 5.00
Pros
- Stock is trading at 0.87 times its book value
Cons
- Company has a low return on equity of 10.4% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2,579 | 2,324 | 2,500 | 3,034 | 3,357 | 2,735 | 2,317 | 2,868 | 2,651 | 3,294 | 3,768 | 4,211 | 4,301 | |
| 2,455 | 2,149 | 2,263 | 2,712 | 2,941 | 2,433 | 2,026 | 2,599 | 2,346 | 2,879 | 3,257 | 3,562 | 3,632 | |
| Operating Profit | 124 | 175 | 237 | 322 | 416 | 303 | 291 | 269 | 305 | 415 | 511 | 649 | 669 |
| OPM % | 4.8% | 8% | 9% | 11% | 12% | 11% | 13% | 9% | 12% | 13% | 14% | 15% | 16% |
| -16 | -47 | 7 | 23 | 17 | 24 | 15 | 260 | 54 | 30 | 61 | 50 | 51 | |
| Interest | 163 | 139 | 127 | 125 | 143 | 97 | 83 | 70 | 100 | 121 | 164 | 167 | 148 |
| Depreciation | 89 | 69 | 72 | 73 | 76 | 78 | 80 | 80 | 94 | 101 | 115 | 155 | 163 |
| Profit before tax | -144 | -81 | 45 | 147 | 213 | 153 | 143 | 379 | 165 | 223 | 292 | 377 | 410 |
| Tax % | -38% | -30% | 22% | 34% | 38% | 25% | 8% | 10% | 15% | 23% | 21% | 22% | |
| -89 | -57 | 35 | 97 | 133 | 115 | 132 | 340 | 141 | 173 | 231 | 293 | 316 | |
| EPS in Rs | -14.30 | -9.16 | 5.65 | 15.57 | 21.39 | 18.49 | 21.23 | 54.81 | 20.17 | 27.90 | 37.25 | 43.70 | 48.02 |
| Dividend Payout % | 0% | 0% | 9% | 13% | 14% | 16% | 14% | 7% | 19% | 14% | 13% | 17% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 13% |
| 3 Years: | 17% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 74% |
| 5 Years: | 14% |
| 3 Years: | 39% |
| TTM: | 30% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 39% |
| 5 Years: | 30% |
| 3 Years: | 73% |
| 1 Year: | 101% |
| Return on Equity | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 10% |
| 3 Years: | 10% |
| Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 34 |
| Reserves | 266 | 687 | 721 | 814 | 932 | 1,003 | 1,138 | 1,761 | 1,870 | 2,020 | 2,225 | 2,899 |
| 2,264 | 1,236 | 1,095 | 834 | 1,000 | 999 | 1,137 | 1,047 | 1,112 | 1,348 | 1,892 | 1,691 | |
| 593 | 1,665 | 1,645 | 1,742 | 1,821 | 2,053 | 1,814 | 1,792 | 1,845 | 2,218 | 2,029 | 1,900 | |
| Total Liabilities | 3,154 | 3,620 | 3,492 | 3,421 | 3,784 | 4,086 | 4,119 | 4,631 | 4,858 | 5,617 | 6,176 | 6,523 |
| 1,146 | 2,029 | 2,111 | 2,156 | 2,173 | 2,228 | 2,193 | 2,318 | 2,717 | 3,205 | 3,829 | 4,554 | |
| CWIP | 162 | 181 | 91 | 89 | 137 | 172 | 126 | 243 | 125 | 84 | 98 | 37 |
| Investments | 4 | 28 | 25 | 24 | 21 | 26 | 27 | 336 | 318 | 335 | 381 | 389 |
| 1,843 | 1,382 | 1,265 | 1,152 | 1,453 | 1,660 | 1,774 | 1,734 | 1,698 | 1,993 | 1,867 | 1,543 | |
| Total Assets | 3,154 | 3,620 | 3,492 | 3,421 | 3,784 | 4,086 | 4,119 | 4,631 | 4,858 | 5,617 | 6,176 | 6,523 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -171 | 1,231 | 302 | 502 | 147 | 343 | 137 | 116 | 326 | 439 | 362 | 769 | |
| 175 | -78 | -40 | -103 | -128 | -151 | -148 | 76 | -330 | -503 | -736 | -767 | |
| -4 | -1,168 | -263 | -399 | 3 | -216 | 11 | -189 | -1 | 90 | 354 | 23 | |
| Net Cash Flow | -0 | -15 | -1 | -0 | 22 | -23 | -0 | 4 | -5 | 25 | -20 | 25 |
| Free Cash Flow | -53 | 1,137 | 260 | 373 | 9 | 193 | -11 | -264 | -109 | -103 | -391 | -47 |
| CFO/OP | -136% | 705% | 127% | 156% | 37% | 127% | 53% | 51% | 123% | 108% | 75% | 122% |
Ratios
Consolidated / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 62 | 57 | 57 | 40 | 35 | 76 | 57 | 51 | 59 | 43 | 35 | 30 |
| Inventory Days | 109 | 128 | 129 | 87 | 124 | 146 | 166 | 148 | 209 | 224 | 209 | 139 |
| Days Payable | 55 | 120 | 144 | 152 | 143 | 155 | 158 | 137 | 209 | 222 | 175 | 123 |
| Cash Conversion Cycle | 115 | 66 | 42 | -25 | 17 | 67 | 65 | 62 | 60 | 44 | 70 | 47 |
| Working Capital Days | -110 | -94 | -117 | -78 | -50 | -64 | -79 | -31 | -46 | -63 | -56 | -49 |
| ROCE % | 3% | 5% | 9% | 15% | 20% | 14% | 10% | 9% | 8% | 11% | 12% | 12% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Potable Spirits Revenue Mix % of Net Revenue |
|
|||||||||
| BSPC Revenue Mix % of Net Revenue |
||||||||||
| Ethanol Blending Rate in India % ・Standalone data |
||||||||||
| Ethanol Distillation Capacity KLPD |
||||||||||
| Number of Countries Exported To count |
||||||||||
| Bio-Fuel Revenue Mix % of Net Revenue |
||||||||||
| IMFL Share of Potable Spirits Revenue % |
||||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Apportionment Of Cost Of Acquisition Of Equity Shares Of India Glycols Limited ('Demerged Company'/'The Company'), Ennature Bio Pharma Limited ('Resulting Company 1') And IGL Spirits Limited ('Resulting Company 2') Pursuant To Scheme Of Arrangement Amongst The Company, Resulting Company 1 And Resulting Company 2 And Their Respective Shareholders ('Scheme'/'Scheme Of Arrangement')
- India Glycols shares apportioned 31.77%/20.61%/47.62% across demerged and resulting companies.
-
Update On Analyst / Institutional Investor Meetings.
- Analyst/institutional investor meetings on 7-8 October 2026 changed from in-person to virtual.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Intimation Of Schedule Of Analyst / Institutional Investor Meeting.
- India Glycols to hold non-deal roadshow for analysts/institutional investors on 7-8 October 2026 in Mumbai.
-
Closure of Trading Window
- Trading window closes from 1 October 2026 until 48 hours after Q2 FY2027 results.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from nse
-
Annual Report 2013
from bse
Concalls
-
Sep 2026PPT
-
Sep 2026PPT
-
Sep 2026PPT
-
Sep 2026Transcript PPT REC
-
Aug 2026PPT
-
Jun 2026Transcript PPT REC
-
Feb 2026Transcript PPT
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT
-
Aug 2025PPT
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT REC
-
Aug 2024Transcript PPT REC
-
Jun 2024Transcript PPT REC
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT REC
-
May 2023Transcript PPT REC
-
Feb 2023Transcript PPT REC
-
Feb 2023PPT
-
Nov 2022Transcript PPT REC
-
Aug 2022Transcript PPT REC
-
Jun 2022Transcript PPT REC
-
Feb 2022Transcript PPT REC
-
Nov 2021Transcript PPT REC
-
Aug 2021Transcript PPT REC
Business Segments [1]